Equillium, Inc. financial data

Symbol
EQ on Nasdaq
Industry
Pharmaceutical Preparations
Location
2223 Avenida De La Playa, Suite 105, La Jolla, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 191 % -20.7%
Debt-to-equity 113 % -6.85%
Return On Equity -36.9 % +40.9%
Return On Assets -17.3 % +38.6%
Operating Margin -22.8 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 35.4M shares +2.48%
Common Stock, Shares, Outstanding 35.4M shares +2.48%
Entity Public Float 16M USD -62.9%
Common Stock, Value, Issued 3K USD 0%
Weighted Average Number of Shares Outstanding, Basic 35.3M shares +2.45%
Weighted Average Number of Shares Outstanding, Diluted 36.6M shares +6.21%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 42.6M USD +51.8%
General and Administrative Expense 13.6M USD -17.3%
Operating Income (Loss) -9.71M USD +48.6%
Nonoperating Income (Expense) 57K USD -75%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -11.6M USD +59.8%
Income Tax Expense (Benefit) 512K USD +653%
Net Income (Loss) Attributable to Parent -8.32M USD +54.2%
Earnings Per Share, Basic -0.24 USD/shares +50%
Earnings Per Share, Diluted -0.24 USD/shares +50%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 11.1M USD -56.8%
Cash, Cash Equivalents, and Short-term Investments 33.3M USD -31.2%
Accounts Receivable, after Allowance for Credit Loss, Current 5.89M USD +57.4%
Other Assets, Current 317K USD
Assets, Current 41.9M USD -27%
Property, Plant and Equipment, Net 329K USD 0%
Operating Lease, Right-of-Use Asset 592K USD -40.3%
Other Assets, Noncurrent 53K USD -39.1%
Assets 42.9M USD -27.1%
Accounts Payable, Current 4.49M USD +48.2%
Employee-related Liabilities, Current 1.99M USD +8.15%
Accrued Liabilities, Current 6.9M USD -8.41%
Liabilities, Current 20.2M USD -20%
Operating Lease, Liability, Noncurrent 259K USD -57.5%
Liabilities 20.4M USD -35.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 251K USD -26.2%
Retained Earnings (Accumulated Deficit) -188M USD -4.63%
Stockholders' Equity Attributable to Parent 22.4M USD -16.9%
Liabilities and Equity 42.9M USD -27.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.8M USD -10.1%
Net Cash Provided by (Used in) Financing Activities -1.43M USD
Net Cash Provided by (Used in) Investing Activities -2.83M USD +88.8%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 35.4M shares +2.48%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -11.6M USD +66.3%
Deferred Tax Assets, Valuation Allowance 47.2M USD +1.93%
Deferred Tax Assets, Gross 47.4M USD -0.38%
Operating Lease, Liability 609K USD 0%
Depreciation 32K USD +3.23%
Payments to Acquire Property, Plant, and Equipment 19K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -8.41M USD +52.4%
Lessee, Operating Lease, Liability, to be Paid 663K USD -42.2%
Operating Lease, Liability, Current 350K USD -15.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 169K USD -22.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 219K USD -55.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 54K USD -56.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 28K USD -83.4%
Deferred Tax Assets, Operating Loss Carryforwards 19.6M USD -30.7%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 6.08M USD +3.33%
Lessee, Operating Lease, Liability, to be Paid, Year Four 28K USD -83.4%
Operating Lease, Payments 122K USD -26.9%
Deferred Tax Assets, Net of Valuation Allowance 228K USD -82.5%
Share-based Payment Arrangement, Expense 3.95M USD -6.27%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%